Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
Ann-Elin Meling StoklandMarie AustdalBjørn Gunnar NedrebøSiri CarlsenHanne Brit HetlandLars BreivikHans Olav UelandTorquil WattPer Karkov CramonKristian LøvåsEystein Sverre HusebyeGrethe Åstrøm UelandPublished in: The Journal of clinical endocrinology and metabolism (2023)
Careful lifelong monitoring is indicated to detect recurrence, hypothyroidism, and other autoimmune diseases. Long-term ATD treatment emerges as a beneficial first-line treatment option, especially in patients with young age at onset or presence of TED.